IM Cannabis Corp. (IMCC) Research

IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.

Market snapshot

Symbol
IMCC
Price
$0.18
Day change
-16.54%
Market cap
$17.2M
P/E ratio
-14.53x
52-week range
0.172-3.75
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earnings
in 2 months

Peer companies

  • Akanda Corp. (AKAN)
  • Flora Growth Corp. (FLGC)
  • GRI Bio, Inc. (GRI)
  • Jaguar Health, Inc. (JAGX)
  • Corvex, Inc. (MOVE)
  • NanoVibronix, Inc. (NAOV)
  • ENDRA Life Sciences Inc. (NDRA)
  • RedHill Biopharma Ltd. (RDHL)

Open IM Cannabis Corp. (IMCC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.